Denosumab
Modify Date: 2024-01-22 02:25:33
Denosumab structure
|
Common Name | Denosumab | ||
|---|---|---|---|---|
| CAS Number | 615258-40-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C6404H9912N1724O2004S50 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DenosumabDenosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures[1], also has anti-cancer activity[2]. |
| Name | Denosumab (usan) |
|---|
| Description | Denosumab is a human monoclonal antibody binding to, and inhibiting, the receptor activator of RANKL (TNFSF11). Denosumab can reduce the risk of vertebral, nonvertebral and hip fractures[1], also has anti-cancer activity[2]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C6404H9912N1724O2004S50 |
|---|